Sexual function in women with endometriosis. Sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, an intervention program based on the 5A self-management model will be implemented for each woman diagnosed with endometriosis with the in
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
19 Years to 45 Years
Inclusion criteria
Inclusion criteria: Iranian nationality Consent to participate in the study Primary education level or higher Having primary school education and higher Within reproductive age (19 to 45 years old) Married and sexually active Being the only wife of her husband Diagnosis of endometriosis by a gynecologist Currently undergoing medical treatment for endometriosis and not candidates for surgery during the intervention period and up to one month after the intervention's completion Obtaining a score less than 28 on the standard Female Sexual Function Index (FSFI) questionnaire.
Exclusion criteria
Exclusion criteria: Presence of pregnancy or breastfeeding Women undergoing assisted reproductive techniques History of known mental disorders requiring medication History of substance or alcohol abuse in the participant or her husband Husbands of participants not suffering from premature ejaculation or erectile dysfunction as self-reported by the participant History of participation in educational courses focused on sexual health education History of surgery in the study participants or their husbands, such as prostatectomy, mastectomy, and other breast surgeries (identified through participant questioning and medical record review) History of stressful events in the past 6 months, such as parental death, etc Presence of any disease in the study participants or their husbands that affects sexual function, including systemic diseases such as liver, kidney, and lung failure Cardiovascular diseases Malignant diseases (cancers) Mental illnesses Mood disorders (depression, anxiety) Ulcerative colitis Vasculitis Thyroid and adrenal cortex diseases Diabetes Hypertension Central nervous system disorders Infectious and sexually transmitted diseases (identified through participant questioning and medical record review) Consumption of medications that affect sexual function by the study participants or their husbands, including Psychotropic medications,Cardiac and antihypertensive medications,Thiazide diuretics,Antidepressants,Anticonvulsants,Hypnotics (sleeping pills),Narcotic medications ,Hormonal medications ,Antihistamines,Anti-cancer medications ,Sexual performance-enhancing medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function in women with endometriosis. Timepoint: At the beginning of the study (before the intervention ) and one month after the end of the intervention. Method of measurement: Female Sexual Function Index (FSFI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahnaz Noroozi
Esfahan University of Medical Sciences
Outcome results
None listed